BDSX
Biodesix Inc
27.70$
+1.4%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 33.3% | 40.0% | 32.7% | 49.7% | 42.8% | 40.6% | 34.3% | 37.0% | 37.6% | 37.2% | 43.2% | 45.7% | |
| 22.9% | 26.5% | 13.2% | 36.4% | 30.6% | 27.0% | 20.4% | 23.6% | 18.8% | 21.7% | 27.0% | 31.5% | |
| 22.9% | 26.5% | 13.2% | 36.4% | 30.6% | 27.0% | 20.4% | 23.6% | 18.8% | 21.7% | 27.0% | 31.5% | |
| 6.7% | 7.7% | 11.3% | 8.7% | 7.8% | 8.8% | 8.9% | 8.5% | 14.3% | 10.3% | 10.0% | 9.7% | |
| 1.5% | 1.4% | 1.6% | 1.0% | 1.2% | – | – | – | 1.6% | – | – | – | |
| 17.3% | 15.2% | 17.2% | 13.0% | 14.6% | 15.5% | 17.4% | 17.1% | 16.9% | 17.2% | 15.9% | 15.8% | |
| 9.7% | 8.0% | 8.5% | 5.9% | 6.3% | 6.0% | 6.2% | 5.6% | 4.9% | 4.4% | 3.6% | 3.1% | |
| 101.7% | 95.4% | 106.3% | 68.7% | 72.9% | 78.5% | 87.2% | 98.7% | 101.9% | 102.8% | 90.4% | 90.4% | |
| 37.6% | 33.7% | 35.8% | 15.2% | 12.6% | 14.7% | 15.4% | 17.3% | 20.5% | 19.9% | 15.3% | 16.0% | |
| 1.3% | 0.3% | 0.4% | 0.3% | 0.6% | 0.8% | 1.3% | 1.4% | 1.6% | 1.6% | 1.5% | 1.7% | |
| 3.3% | 3.0% | 3.7% | 1.9% | 2.5% | 2.3% | 3.4% | 3.4% | 4.1% | 3.5% | 3.9% | 2.3% | |
| 28.7% | 35.5% | 40.7% | 30.9% | 35.1% | 37.4% | 42.5% | 53.3% | 53.1% | 54.2% | 49.1% | 49.1% | |
| -1.7% | 4.6% | -6.3% | 31.3% | 27.1% | 21.5% | 12.8% | 1.3% | -1.9% | -2.8% | 9.6% | 9.6% | |
| -472.9% | -423.4% | -496.8% | -383.3% | -442.1% | -475.6% | -549.2% | -552.8% | -556.5% | -569.0% | -534.2% | -538.0% | |
| 4.6% | 4.7% | 5.6% | 5.5% | 7.1% | 7.5% | 8.5% | 8.4% | 8.5% | 9.2% | 10.2% | 10.8% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.